Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT01971593

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:56.322392+00:00

Published At

2018-05-04T00:00:00+00:00

Record Updated At

2018-05-04

Results Posted At

2018-05-04

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Tetralogy of Fallot", "Transposition of the Great Vessels With an Arterial Switch", "Single Ventricle With a Fontan Palliation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-05-04"

protocolSection.identificationModule.nctId

"NCT01971593"

protocolSection.identificationModule.officialTitle

"Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE4"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-05-04"

Study condition terms

• Tetralogy of Fallot (protocolSection.conditionsModule.conditions)
• Transposition of the Great Vessels With an Arterial Switch (protocolSection.conditionsModule.conditions)
• Single Ventricle With a Fontan Palliation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.